OTCMKTS:DSRLF DiaSorin (DSRLF) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free DSRLF Stock Alerts $88.45 0.00 (0.00%) (As of 04/17/2024 ET) Add Compare Share Share Today's Range$88.45▼$88.4550-Day Range$88.45▼$92.2252-Week Range$86.00▼$120.00VolumeN/AAverage Volume0 shsMarket Capitalization$4.84 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get DiaSorin alerts: Email Address Ad DarwinYour Next Portfolio Star: Revealing 2024's Top Stock Pick We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)Click here to download your report About DiaSorin Stock (OTCMKTS:DSRLF)DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS. It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.Read More DSRLF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DSRLF Stock News HeadlinesApril 15, 2024 | americanbankingnews.comDiaSorin S.p.A. (OTCMKTS:DSRLF) Short Interest UpdateDecember 8, 2023 | morningstar.comDiasorin SpA DIAApril 18, 2024 | Insiders Exposed (Ad)This consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.July 27, 2023 | msn.comDiaSorin S.p.A. reports 1H resultsMay 9, 2023 | msn.comDiaSorin confirms 2023 guidance after Q1 resultsApril 6, 2023 | barrons.comDiaSorin S.p.A.March 29, 2023 | seekingalpha.comDiaSorin S.p.A. (DSRLF) Q4 2022 Earnings Call TranscriptMarch 4, 2023 | seekingalpha.comDiaSorin: Overvalued Italian Healthcare CompanyApril 18, 2024 | Darwin (Ad)Your Next Portfolio Star: Revealing 2024's Top Stock Pick We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)February 15, 2023 | wsj.comCytek(R) Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinFebruary 13, 2023 | finance.yahoo.comCytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinOctober 31, 2022 | reuters.comDIAS.MI - DiaSorin SpA | Stock Price & Latest News | ReutersAugust 8, 2022 | seekingalpha.comDiaSorin S.p.A. (DSRLF) CEO Carlo Rosa on Q2 2022 Results - Earnings Call TranscriptOctober 23, 2021 | finance.yahoo.comSouthwest Airlines Company (LUV) stock forecast and price targetAugust 2, 2021 | seekingalpha.comDiaSorin S.p.A. 2021 Q2 - Results - Earnings Call PresentationSee More Headlines Receive DSRLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DiaSorin and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/18/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:DSRLF CUSIPN/A CIKN/A Webwww.diasoringroup.com Phone391614871FaxN/AEmployees3,386Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.43 billion Price / SalesN/A Cash Flow$9.09 per share Price / Cash Flow9.73 Book Value$29.27 per share Price / Book3.02Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.27 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Carlo Rosa (Age 58)CEO, GM & Executive Director Comp: $1.87MDr. Chen Menachem Even (Age 61)Chief Commercial Officer, Senior Corporate VP of Commercial Operations & Executive Director Comp: $912.75kMr. Piergiorgio Pedron (Age 53)Senior Corporate VP, CFO & Corporate Accounting Documents Officer Mr. Fabrizio Piercarlo BonelliCorporate VP & Chief Technology OfficerDr. Riccardo FavaCorporate Vice President of Communication & Investor RelationsMr. Ulisse SpadaCorporate VP, Head of the Legal Department, Secretary & General CounselMr. Stefano Ronchi (Age 64)Senior Corporate Vice President of Human Resources Mr. Angelo Rago (Age 61)President of Luminex Corporation More ExecutivesKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors DSRLF Stock Analysis - Frequently Asked Questions How have DSRLF shares performed in 2024? DiaSorin's stock was trading at $99.7828 at the beginning of the year. Since then, DSRLF stock has decreased by 11.4% and is now trading at $88.45. View the best growth stocks for 2024 here. Are investors shorting DiaSorin? DiaSorin saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 537,600 shares, an increase of 11.2% from the March 15th total of 483,400 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days. View DiaSorin's Short Interest. How do I buy shares of DiaSorin? Shares of DSRLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:DSRLF) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBiden out June 13; Kamala won’t replace him?Paradigm PressUrgent alert: open this for a huge profit potentialTimothy SykesOptions trading has suddenly become more reliable.Eagle PublishingThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaSorin S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.